| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |